Aihui Ma

729 total citations
17 papers, 519 citations indexed

About

Aihui Ma is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Aihui Ma has authored 17 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Immunology. Recurrent topics in Aihui Ma's work include Ubiquitin and proteasome pathways (5 papers), Cancer-related Molecular Pathways (4 papers) and Immunotherapy and Immune Responses (3 papers). Aihui Ma is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Cancer-related Molecular Pathways (4 papers) and Immunotherapy and Immune Responses (3 papers). Aihui Ma collaborates with scholars based in China and United States. Aihui Ma's co-authors include Yongzhong Liu, Zhaojuan Yang, Yun Liu, Boshi Wang, Li Zhang, Guiqin Xu, Tiantian Jing, Ming Tang, Lin Wu and Xiaoli Xu and has published in prestigious journals such as Nature Communications, PLoS ONE and Hepatology.

In The Last Decade

Aihui Ma

16 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aihui Ma China 12 425 153 144 78 48 17 519
Chenming Wu China 13 563 1.3× 237 1.5× 101 0.7× 67 0.9× 71 1.5× 22 658
Dongyi Wan China 10 326 0.8× 153 1.0× 146 1.0× 37 0.5× 31 0.6× 16 481
Yibin Ren China 12 365 0.9× 149 1.0× 163 1.1× 85 1.1× 90 1.9× 13 531
Huairui Yuan China 10 432 1.0× 94 0.6× 159 1.1× 108 1.4× 46 1.0× 14 600
Qingyu Luo China 15 425 1.0× 162 1.1× 128 0.9× 50 0.6× 52 1.1× 21 540
Douglas B. Fox United States 7 358 0.8× 117 0.8× 191 1.3× 57 0.7× 31 0.6× 8 505
Yijun Lu China 11 225 0.5× 131 0.9× 120 0.8× 97 1.2× 72 1.5× 15 421
J Tian China 3 378 0.9× 193 1.3× 84 0.6× 53 0.7× 28 0.6× 7 495
Shao‐Lan Qin China 13 269 0.6× 179 1.2× 140 1.0× 93 1.2× 19 0.4× 26 482

Countries citing papers authored by Aihui Ma

Since Specialization
Citations

This map shows the geographic impact of Aihui Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aihui Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aihui Ma more than expected).

Fields of papers citing papers by Aihui Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aihui Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aihui Ma. The network helps show where Aihui Ma may publish in the future.

Co-authorship network of co-authors of Aihui Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Aihui Ma. A scholar is included among the top collaborators of Aihui Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aihui Ma. Aihui Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Opdenaker, Lynn M., et al.. (2025). B cells enhance IL-1 beta driven invasiveness in triple negative breast cancer. Scientific Reports. 15(1). 2211–2211. 3 indexed citations
2.
3.
Li, Shang, Yongyou Zhu, Aihui Ma, et al.. (2023). The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling. Breast Cancer Research. 25(1). 144–144. 3 indexed citations
4.
5.
Zhang, Li, Yun Liu, Boshi Wang, et al.. (2018). POH1 deubiquitinates pro-interleukin-1β and restricts inflammasome activity. Nature Communications. 9(1). 4225–4225. 33 indexed citations
6.
Ma, Aihui, Ming Tang, Li Zhang, et al.. (2018). USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis. Oncogene. 38(13). 2405–2419. 89 indexed citations
7.
Liu, Yun, Li Zhang, Boshi Wang, et al.. (2018). Requirement for POH1 in differentiation and maintenance of regulatory T cells. Cell Death and Differentiation. 26(4). 751–762. 14 indexed citations
8.
Qian, Yu, Boshi Wang, Aihui Ma, et al.. (2016). USP16 Downregulation by Carboxyl-terminal Truncated HBx Promotes the Growth of Hepatocellular Carcinoma Cells. Scientific Reports. 6(1). 33039–33039. 32 indexed citations
9.
Wang, Boshi, Aihui Ma, Li Zhang, et al.. (2015). POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation. Nature Communications. 6(1). 8704–8704. 97 indexed citations
10.
Xu, Guiqin, Li Zhang, Aihui Ma, et al.. (2015). SIP1 is a downstream effector of GADD45G in senescence induction and growth inhibition of liver tumor cells. Oncotarget. 6(32). 33636–33647. 14 indexed citations
11.
Sun, Jiabin, Boshi Wang, Yun Liu, et al.. (2014). Transcription factor KLF9 suppresses the growth of hepatocellular carcinoma cells in vivo and positively regulates p53 expression. Cancer Letters. 355(1). 25–33. 63 indexed citations
12.
Wang, Yang, Aihui Ma, Li Zhang, et al.. (2014). The combinatory effects of PPAR-γ agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cells. International Journal of Molecular Medicine. 34(1). 262–268. 24 indexed citations
13.
Liu, Yun, Jia‐Bin Sun, Aihui Ma, et al.. (2013). AKT hyperactivation confers a Th1 phenotype in thymic Treg cells deficient in TGF‐β receptor II signaling. European Journal of Immunology. 44(2). 521–532. 8 indexed citations
14.
Zhang, Li, Aihui Ma, Feng Zhang, et al.. (2013). c-MYC overexpression overrides TAK1 dependency in efficient tumorigenicity of AKT-transformed cells. Cancer Letters. 336(2). 290–298. 3 indexed citations
15.
16.
Li, Jingyi, Yun Liu, Boshi Wang, et al.. (2013). Myeloid TGF-β signaling contributes to colitis-associated tumorigenesis in mice. Carcinogenesis. 34(9). 2099–2108. 12 indexed citations
17.
Yang, Zhaojuan, Li Zhang, Aihui Ma, et al.. (2011). Transient mTOR Inhibition Facilitates Continuous Growth of Liver Tumors by Modulating the Maintenance of CD133+ Cell Populations. PLoS ONE. 6(12). e28405–e28405. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chenming Wu Breakdown of academic impact, for papers by Dongyi Wan Breakdown of academic impact, for papers by Yibin Ren Breakdown of academic impact, for papers by Huairui Yuan Breakdown of academic impact, for papers by Qingyu Luo Breakdown of academic impact, for papers by Douglas B. Fox Breakdown of academic impact, for papers by Yijun Lu Breakdown of academic impact, for papers by J Tian Breakdown of academic impact, for papers by Shao‐Lan Qin
Rankless by CCL
2026